STOCK TITAN

Grapefruit USA, Inc. Issues Update Concerning Initial Informal Acquisition Inquiry, Announces Development of Memorandum of Understanding for Potential Joint Venture

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Rhea-AI Summary

Grapefruit USA, Inc. (OTCQB: GPFT), a licensed California cannabis company, announced discussions with a Canadian cannabis firm regarding a potential acquisition. These discussions include creating a memorandum of understanding for a joint venture to manufacture and distribute Grapefruit's patented Hourglass™ THC/Cannabinoid delivery cream in Canada. The CEO highlighted a significant 714% year-over-year revenue increase, sparked interest from the market, and the potential for expanded product availability. Grapefruit emphasizes that these talks are preliminary and may change at any time.

Positive
  • 714% year-over-year revenue increase.
  • Potential for a joint venture to expand into the Canadian market.
  • Interest in the patented Hourglass™ product indicates strong market demand.
Negative
  • Discussions are preliminary and may not lead to a finalized agreement.
  • The potential joint venture may face regulatory hurdles.

LOS ANGELES and DESERT HOT SPRINGS, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- via InvestorWire --Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere, fully licensed California-based cannabis company, is updating its recent announcement that it has been approached by a Canadian cannabis company to enter into discussions concerning a potential acquisition transaction. The discussions have evolved to include development of a memorandum of understanding (“MOU”) setting forth terms under which the parties could enter into a joint venture to jointly manufacture, distribute and market Grapefruit’s products, including, but not limited to, Grapefruit’s patented disruptive Hourglass™ THC/Cannabinoid time-release delivery cream throughout Canada.        

Bradley J. Yourist, Grapefruit CEO, commented, “As previously announced, Grapefruit is not surprised that we have been approached concerning a potential acquisition, in light of the Company’s recent disclosure concerning its 714% year-over-year revenue increase; the public reaction to the Company’s patented, disruptive Hourglass™ THC/Cannabinoid delivery cream; and recent announcements by U.S. Senate Majority Leader Chuck Schumer concerning prioritization of the federal legalization of cannabis by de-scheduling THC. Grapefruit has always been fundamentally driven by compliance, so management decided it was incumbent upon the Company to make this announcement to prevent possible selective leaks of this material and heretofore nonpublic information and/or to prevent insider trading. As part of the parties’ deliberations, we have considered creation of a joint venture, which we believe may be put into place more easily and promptly than a full transnational reorganization transaction that could require regulatory oversight and associated complications. A joint venture may precede a reorganization transaction. Such an approach might facilitate the rapid introduction of Hourglass™ and other Grapefruit products into the Canadian market. Once again, that being said, we wish to emphasize that the discussions reported here are preliminary in nature and may be terminated at any time. Grapefruit will update the public as necessary on these discussions as events proceed.”        

To learn more about Grapefruit, please visit InvestorBrandNetwork:
https://www.investorbrandnetwork.com/clients/grapefruit-usa-inc/

To learn more about Grapefruit’s new sustained-release Hourglass™ THC + Cannabinoid Topical Delivery Cream, please watch this promotional video https://www.youtube.com/watch?v=6cU9MJMgH1w&feature=youtu.be and visit our website at:
https://grapefruitblvd.com/hourglass/

For investor information, please visit our website at:
https://grapefruitblvd.com/investor-relations/

Follow us on Facebook, Instagram, LinkedIn and Twitter:
Facebook | Instagram | LinkedIn | Twitter

About Grapefruit

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Road, approximately 14 miles north of downtown Palm Springs. To obtain further information on Grapefruit and its operations, please visit the Company’s website at https://grapefruitblvd.com/.

Safe Harbor Statement

Grapefruit cautions that any statement included in this press release that is not a description of historical facts is a forward-looking statement. Many of these forward-looking statements contain the words "anticipate," "believe," "estimate," "may" "intend," "expect" and similar expressions. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties inherent in Grapefruit’s business, including, without limitation: the Company may not ever obtain additional funds necessary to support its business development and growth plans; and the Company may not ever achieve the market success to reach or sustain a profitable business. In addition, there are risks and uncertainties related to economic recession or terrorist actions, competition from much larger cannabis companies, unexpected costs and delays, potential product liability claims, and many other factors. More detailed information about Grapefruit and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, its Quarterly Report on Form 10-Q for the period ended Sept. 30, 2020, and its Registration Statement on Form S-1/A. Such documents may be read free of charge on the SEC’s website at www.sec.gov. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Grapefruit undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Investor Relations Contact:
Bradley Yourist
ir@grapefruitblvd.com
18776 Blue Dream Crossing, Unit LL1 53-07
Desert Hot Springs, California 92240
(760) 205-1382
https://grapefruitblvd.com/

Please be aware that our social media accounts can be used from time to time for additional material events. They can be found here:

Grapefruit USA:
Facebook: https://www.facebook.com/Grapefruit-Boulevard-2304698596251925/
Instagram: https://www.instagram.com/grapefruit_usa/
Twitter: https://twitter.com/grapefruitusa
LinkedIn: https://www.linkedin.com/company/grapefruit-boulevard/
Weedmaps: https://weedmaps.com/brands/grapefruit

Corporate Communications:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com 


FAQ

What is the latest news about Grapefruit USA (GPFT)?

Grapefruit USA is in discussions with a Canadian cannabis company for a potential acquisition and a joint venture to market its products, particularly the Hourglass™ delivery cream.

What led to the acquisition discussions for GPFT?

The discussions were spurred by Grapefruit's impressive 714% revenue growth and the interest in its innovative Hourglass™ product.

What is the purpose of the joint venture with the Canadian company for GPFT?

The joint venture aims to manufacture and distribute Grapefruit's cannabis products, enhancing their presence in the Canadian market.

What are the potential challenges for Grapefruit USA's acquisition talks?

The preliminary nature of the discussions and possible regulatory complications could hinder the acquisition or joint venture.

GRAPEFRUIT USA INC

OTC:GPFT

GPFT Rankings

GPFT Latest News

GPFT Stock Data

932.62k
703.31M
26.81%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Wilmington